Surmodics reported $-1923000 in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Abbott ABT:US $ 1862M 248M
Align Technology ALGN:US $ 268.97M 86.93M
Anika Therapeutics ANIK:US $ -2262000 1.28M
Arrowhead Research ARWR:US $ -31868000 3.64M
Baxter International BAX:US $ 476M 50M
Bioscrip BIOS:US $ 48.09M 19M
Boston Scientific BSX:US $ 576M 203M
Cryolife CRY:US $ 4.72M 1.78M
Edap Tms EDAP:US -427000 666K
Edwards Lifesciences EW:US $ 544.5M 154.6M
Genmark Diagnostics GNMK:US $ -2087000 821K
Haemonetics HAE:US $ 25.53M 20.71M
Heron Therapeutics HRTX:US $ -60469000 8.36M
Johnson & Johnson JNJ:US $ 4310M 2685M
Merit Medical Systems MMSI:US $ 26.62M 12.42M
Mesa Laboratories MLAB:US $ 3.12M 1.26M
Nektar Therapeutics NKTR:US $ -110205000 813K
Oxford Immunotec Global OXFD:US 275K 10.11M
Providence Service PRSC:US $ 26.72M 549K
Stryker SYK:US $ 843M 253M
Surmodics SRDX:US $ -1923000 11.41M
Trinity Biotech TRIB:US 6.29M 3.21M